Accessibility Menu
Oncologix Tech logo

Oncologix Tech

(OTC) OCLG

Current Price$0.00
Market Cap$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-100%
5 Year-97%
1 Year+0%
1 Month+0%

Oncologix Tech Financials at a Glance

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.16M

Net Income (TTM)

-$1.73M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

22.67 (High)

Price

$0.00

Volume

15,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 21, 2015

OCLG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncologix Tech

Industry

Healthcare Providers and Services

CEO

Frank Ikechukwu Igwealor, MBA, CPA

Headquarters

Lafayette, CA 70508, US

OCLG Financials

Key Financial Metrics (TTM)

Gross Margin

20.05%

Operating Margin

-30.35%

Net Income Margin

-83.19%

Return on Equity

94.77%

Return on Capital

-52.03%

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

15.00K

Avg. Volume

68.26K

Financials (TTM)

Gross Profit

$578.41K

Operating Income

-$389.19K

EBITDA

-$644.92K

Operating Cash Flow

-$213.84K

Capital Expenditure

-$1.18K

Free Cash Flow

-$215.02K

Cash & ST Invst.

$4.85K

Total Debt

$23.62K

Oncologix Tech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$870.16

N/A

Employees

191

N/A

Net Income

-$18.77K

+96.8%

EBITDA

-$18.77K

+95.2%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$4.85K

-83.2%

Total Debt

$23.62K

-99.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$23.62K

-94.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$18.77K

+90.5%

Operating Cash Flow

-$18.77K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMLHAmerican Leisure Holdings, Inc.
$0.00+0.00%
IFANIFAN Financial, Inc.
$0.00+0.00%
TKCITurnKey Capital, Inc.
$0.06-31.03%
OHCSOptimus Healthcare Services, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.52-0.04%
RIVNRivian Automotive
$16.66+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.72+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.08-0.01%

Questions About OCLG

What is the current price of Oncologix Tech?

Oncologix Tech is trading at $0.00 per share.

What is the 52-week range for Oncologix Tech?

Over the past 52 weeks, Oncologix Tech has traded between $0.00 and $0.00.

How much debt does Oncologix Tech have?

As of the most recent reporting period, Oncologix Tech reported total debt of $0.00.

How much cash does Oncologix Tech have on hand?

Oncologix Tech reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Oncologix Tech’s dividend yield?

Oncologix Tech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.